DrugPatentWatch Database Preview
Taro Company Profile
Email this page to a colleague
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and forty-four approved drugs.
There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.
There are thirty-three patent family members on TARO drugs in twelve countries and one hundred and fifty-two supplementary protection certificates in fourteen countries.
Summary for Taro
| International Patents: | 33 |
| US Patents: | 8 |
| Tradenames: | 128 |
| Ingredients: | 111 |
| NDAs: | 244 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | LAMOTRIGINE | lamotrigine | TABLET, CHEWABLE;ORAL | 079204-002 | Feb 4, 2009 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Taro | CICLOPIROX | ciclopirox | CREAM;TOPICAL | 076790-001 | Apr 12, 2005 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Taro Pharm Inds | HYDROCORTISONE BUTYRATE | hydrocortisone butyrate | SOLUTION;TOPICAL | 076364-001 | Jan 14, 2004 | AT | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Taro | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 078960-001 | Feb 1, 2010 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Taro | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | TABLET;ORAL | 090817-001 | May 28, 2010 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | ⤷ Try it Free |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,071,523 | ⤷ Try it Free |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ⤷ Try it Free |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ⤷ Try it Free |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5474347 | ⤷ Try it Free |
| Canada | 2612578 | ⤷ Try it Free |
| Japan | 2013014634 | ⤷ Try it Free |
| Brazil | 112012017554 | ⤷ Try it Free |
| China | 103087095 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1912999 | 1490062-5 | Sweden | ⤷ Try it Free | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| 2563920 | CR 2019 00001 | Denmark | ⤷ Try it Free | PRODUCT NAME: INOTERSEN AND SALT THEREOF, INCLUDING SODIUM SALTS; REG. NO/DATE: EU/1/18/1296 20180710 |
| 0463756 | C990005 | Netherlands | ⤷ Try it Free | PRODUCT NAME: SILDENAFIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SILDENAFIL CITRAAT; NATL REGISTRATION NO/DATE: EU/1/98/077/001-012 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| 0347066 | 10399030 | Germany | ⤷ Try it Free | PRODUCT NAME: ESCITALOPRAMOXALAT; NAT. REGISTRATION NO/DATE: 55880.00.00 55880.01.00 55880.02.00 55880.03.00 55884.00.00 55884.01.00 55884.02.00 55884.03.00 55888.00.00 55888.01.00 55888.02.00 55888.03.00 20030408 FIRST REGISTRATION: SCHWEDEN 17084 17085 17086 17087 20011207 |
| 2506844 | 2018C/022 | Belgium | ⤷ Try it Free | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
